HekaBio

Tokyo, Japan

HekaBio is an ecosystem for a healthcare development platform that provides therapeutic treatments in oncology and ophthalmology.

Jun 2025

Corporate Round

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are HekaBio's investors?

HekaBio's investors include Ohara Pharmaceutical, Essential Pharma, Alfresa Holdings, Media Future, Toho Holdings.

Where is HekaBio headquartered?

HekaBio is headquartered in Tokyo, Japan.

What does HekaBio do?

HekaBio is an ecosystem for a healthcare development platform that provides therapeutic treatments in oncology and ophthalmology.

What stage is HekaBio at?

HekaBio is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 16, 2025.

MLA

"HekaBio — Funding & Investors." VCBacked, June 16, 2025, https://www.vcbacked.co/company/hekabio. Accessed July 3, 2026.

APA

VCBacked. (2025). HekaBio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/hekabio

Wikipedia (cite web)

{{cite web |title=HekaBio — Funding & Investors |url=https://www.vcbacked.co/company/hekabio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 16, 2025.